Soligenix Reports Positive Results for HyBryte™ Compatibility Study in Cutaneous T-Cell Lymphoma Treatment

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to tre...

May 05, 2023 | Friday | News
New ACR Breast Cancer Screening Guidelines call for earlier and more-intensive screening for high-risk women

Other Notable Updates:   New American College of Radiology® (ACR®) breast cancer screening guidelines now call for all women &mdas...

May 04, 2023 | Thursday | News
EirGenix's EG1206A Meets Phase 1 Trial Objectives as Breast Cancer Biosimilar

EG1206A is a biosimilar drug of the second-generation HER2-positive antibody drug Perjeta® (pertuzumab). EG1206A has a unique binding mechanism for HER...

May 03, 2023 | Wednesday | News
Ascletis' Once-Daily Oral FASN Inhibitor, ASC40, Meets Phase II Endpoint for Acne

ASC40 is an oral, selective small molecule inhibitor of FASN. Mechanisms of ASC40 for acne are (1) direct inhibition of facial sebum production, through in...

May 03, 2023 | Wednesday | News
Genomic Urine Test Detects Bladder Cancer from DNA Up to 12 Years Before Clinical Signs and Symptoms Appear

A new genomic urine test can help doctors accurately predict bladder cancer as many as 12 years before clinical signs and symptoms emerge and long before a...

May 02, 2023 | Tuesday | News
Curasight and Curium announce global partnership for uTRACE® in prostate cancer

Curasight to develop its proprietary uTRACE® PET imaging technology to obtain regulatory approval in EU and USA, with Curium responsible for man...

May 02, 2023 | Tuesday | News
Exagen Announces Campaign for Lupus Awareness Month

Lupus Awareness Month occurs every May and is an opportunity for lupus-focused organizations to take intentional steps in creating awareness around lupus a...

May 02, 2023 | Tuesday | News
Could Tumoroids Solve the Problem of High Attrition in Cancer Trials?

There is growing recognition that the experimental model systems used in many cancer research projects, which include 2D cell cultures, patient-derived xen...

May 01, 2023 | Monday | News
Study Suggests Catalyst for Human Brain Evolution

More than a million years ago, large chunks of the human genome were rearranged—a chance event during egg or sperm formation that led to the deletion...

May 01, 2023 | Monday | News
Abbott Completes Acquisition of Cardiovascular Systems, Inc.

The transaction provides Abbott with a complementary solution for treating vascular disease. CSI's leading atherectomy system prepares vessels for angiopla...

April 28, 2023 | Friday | News
UCLA Health and CHOC collaborate to enhance access to pediatric congenital cardiac care

"Our shared vision is one program offered at two sites to provide patients with the right care in a location close to home," said Dr. Glen Van Arsdell, who...

April 28, 2023 | Friday | News
Roche's Columvi Gets CHMP Nod for Fixed-Duration Use in Diffuse Large B-cell Lymphoma

The recommendation is based on results from the phase I/II NP30179 study, where Columvi given as a fixed course induced early and long-lasting complete r...

April 27, 2023 | Thursday | Regulatory
Tofersen's FDA accelerated approval highlights blood neurofilament light chain's significance as surrogate endpoint in neurology trials

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today...

April 26, 2023 | Wednesday | News
Trust Your Gut: Balancing the Microbiome for Better Health

A balanced microbiome plays an important role in maintaining human health by promoting protective immune responses and limiting excessive inflammation. But...

April 25, 2023 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close